1. Introduction {#sec1-antioxidants-08-00269}
===============

The progress of the obesity pandemic is still substantially underestimated but is alarming \[[@B1-antioxidants-08-00269]\]. Obese individuals have a lower quality of life and more risk of developing several clinical problems \[[@B2-antioxidants-08-00269]\]. Obesity is a chronic status with sub-clinical inflammation which is associated with the abnormal synthesis of cytokine/adipokines, leading to an increase of radical oxygen species (ROS) \[[@B3-antioxidants-08-00269]\]. Therefore, obesity is not *per se* a disease; rather, it is a status that contributes to the imbalance of anti-inflammatory and oxidative stress biochemical pathways \[[@B4-antioxidants-08-00269]\]. Opportune antioxidant defenses counteract the action of ROS in different organs and are improved by diverse biomolecules \[[@B5-antioxidants-08-00269],[@B6-antioxidants-08-00269],[@B7-antioxidants-08-00269]\], functional food and diet nutrients \[[@B8-antioxidants-08-00269],[@B9-antioxidants-08-00269]\]. It is worthy of note that, recently, hyperglycemic crisis was linked to oxidative stress in diabetic patients \[[@B10-antioxidants-08-00269]\]. While ketoacidosis is not safe for human health, it is well known that the ketogenic diet (KD) is safe. KD is a nutritional regimen in which the amount of carbohydrate is maintained at less than 30 g per day \[[@B11-antioxidants-08-00269]\]. Although its application initially was a therapeutic regimen for refractory epilepsy, today it is often used to lose weight \[[@B12-antioxidants-08-00269]\]. KD was proved to possess antioxidant and anti-inflammatory properties as well as to regulate obese subjects in stage 1 of the Edmonton Obesity Staging System (EOSS) and their microRNA (miR) expression profile \[[@B11-antioxidants-08-00269],[@B13-antioxidants-08-00269],[@B14-antioxidants-08-00269],[@B15-antioxidants-08-00269]\]. The 11 miRNAs analyzed previously in this subject category were normalized with KD when compared to lean subjects. Besides being regulators of the metabolic network in which ROS are always produced, these miRs are also able to counteract inflammatory and oxidative stress \[[@B16-antioxidants-08-00269]\].

2. Materials and Methods {#sec2-antioxidants-08-00269}
========================

2.1. Population {#sec2dot1-antioxidants-08-00269}
---------------

Ethical approval for all human studies was granted in accordance with the Regional Ethics Committee (REC) (\#120-18052018). Subjects were also excluded if they showed the presence of hypertension and/or were on medication. The study was considered not to have set up clinical trials and was not registered as such. Written informed consent was obtained from participants which conformed to the standards of ethical practice as outlined in the declaration of Helsinki. The exclusion criteria included diabetes, renal diseases, liver dysfunction, a history of alcohol or drug abuse, and neoplastic diseases in the five years prior to the study.

2.2. Immunoblot Analysis and RNAs Extraction {#sec2dot2-antioxidants-08-00269}
--------------------------------------------

Blood samples were collected, and red blood cells and lysates for catalase (CAT) expression protein were harvested using the antibody (abcam \# ab16731). The protein concentration in samples was estimated as described in \[[@B17-antioxidants-08-00269],[@B18-antioxidants-08-00269],[@B19-antioxidants-08-00269],[@B20-antioxidants-08-00269]\]. Serum plasma was then used for functional genomics assay. Total RNA was extracted from 200 μL of blood serum or plasma by using an miRNeasy Serum/Plasma Kit (Qiagen, Venlo, The Netherlands) in order to lower potential contaminants \[[@B15-antioxidants-08-00269],[@B21-antioxidants-08-00269]\] and according to the manufacturer's instructions.

2.3. NanoString Sample Preparation and Data Analysis {#sec2dot3-antioxidants-08-00269}
----------------------------------------------------

For the n-counter flex of NanoString Technology, 100 ng of RNA/miR was used as input. miRs were then hybridized with an nCounter Human-V3 miRNA Expression Assay CodeSet overnight at 65 °C and as previously described in \[[@B22-antioxidants-08-00269],[@B23-antioxidants-08-00269]\]. In order to obtain robust results, the coefficient of variation (CV), expressing the ratio of the standard deviation to the mean and expressed as a percentage, was chosen as 30%. The miRs known to be linked to blood hemolysis were excluded from the analysis \[[@B24-antioxidants-08-00269],[@B25-antioxidants-08-00269]\].

2.4. In Silico Prediction of hsa-miR Target Genes {#sec2dot4-antioxidants-08-00269}
-------------------------------------------------

In order to identify genes as targets of hsa-miRs from the array analysis, we performed in silico analysis. The in silico identification of the target genes was performed using miRTargetLink Human (<https://ccb-web.cs.uni-saarland.de/mirtargetlink/>) and DIANA Tools (<http://diana.imis.athena-innovation.gr/DianaTools/index.php>) databases. This latter database was used to check which miRNA target genes were already validated experimentally.

2.5. Statistical Analysis {#sec2dot5-antioxidants-08-00269}
-------------------------

Prism GraphPad Prism version 5.0 for Windows (GraphPad Software, San Diego, CA, USA) was used to plot the results. Differences within and between groups were evaluated by the *t*-test and one-way ANOVA followed by a multi-comparison Bonferroni test (\* *p* \< 0.05).

3. Results {#sec3-antioxidants-08-00269}
==========

3.1. Characteristics of Subjects {#sec3dot1-antioxidants-08-00269}
--------------------------------

A total of 43 subjects, divided into categories of obese, lean and on a ketogenic diet (KD), were selected, with numbers for obese subjects of *n* = 14, lean of *n* = 17 and KD of *n* = 12. The subjects' characteristics are described in [Table 1](#antioxidants-08-00269-t001){ref-type="table"}.

3.2. Comparison of Obese, Lean and KD Array Profiles {#sec3dot2-antioxidants-08-00269}
----------------------------------------------------

The heatmap and hierarchical clustering based on the most differentially expressed hsa-miRs are shown in [Figure 1](#antioxidants-08-00269-f001){ref-type="fig"}, including the signatures of hsa-let-7b-5p, hsa-miR-143-3p, hsa-miR-148b-3p, hsa-miR-26a-5p, hsa-miR-502-5p, hsa-miR-520h, hsa-miR-548d-3p, hsa-miR-590-5p and hsa-miR-644a. In particular, KD, compared to obese subjects, normalized the expression levels of hsa-let-7b-5 (8/12), hsa-miR-143-3p (9/12), hsa-miR-148b-3p (10/12), hsa-miR-590-5p (10/12), hsa-miR-520h (8/12) and hsa-miR-644a (9/12), which were expressed in more than 65% of subjects, while 100% was achieved for hsa-miR-548d-3p (12/12). At least 50% was reached for hsa-miR-26a-5p (6/12), and hsa-miR-502-5p (7/12). No change was seen for hsa-miR-504-5p. The new hsa-miR-let7e-5p (5/12) and hsa-miR-877 (5/12) here identified showed a less than 50% presence, with the exception of hsa-miR-30a-5p (8/12).

3.3. In Silico Results {#sec3dot3-antioxidants-08-00269}
----------------------

Two different databases were used for the in-silico analysis. Data were compared with respect to the number of target genes experimentally validated in both databases. The results are reported in [Table 2](#antioxidants-08-00269-t002){ref-type="table"}. Although similar results were found for two hsa-miRs (in bold in [Table 2](#antioxidants-08-00269-t002){ref-type="table"}), the numbers of validated targets found for others hsa-miRs were consistently different. In DIANA tools, the numbers of validated target genes were higher in respect to miRtagertLink Human; therefore, DIANA tools were used for further bioinformatics analysis.

3.4. Validated hsa-miR Interaction and Western Blot Analysis of Catalase {#sec3dot4-antioxidants-08-00269}
------------------------------------------------------------------------

Predicted and validated target genes were assessed using DIANA Tools. The new hsa-miR-let7e-5p was found to regulate glutathione peroxidase 7 (GPX7), as shown by string analysis ([Figure 2](#antioxidants-08-00269-f002){ref-type="fig"}A), as well as in silico 3′UTR interaction ([Figure 2](#antioxidants-08-00269-f002){ref-type="fig"}B). In silico 3′UTR regions of tet methylcytosine dioxygenase 3 (TET3) for hsa-miR-520h ([Figure 2](#antioxidants-08-00269-f002){ref-type="fig"}D) interaction and 3′UTR regions of superoxide dismutase 2 (SOD2) for hsa-miR-548d-3p ([Figure 2](#antioxidants-08-00269-f002){ref-type="fig"}F) are shown, as well as string analysis, in [Figure 2](#antioxidants-08-00269-f002){ref-type="fig"}C,E, respectively. String analysis showed that 10 proteins are able to physically interact with GPX7 ([Figure 2](#antioxidants-08-00269-f002){ref-type="fig"}B) as well as with TET3 ([Figure 2](#antioxidants-08-00269-f002){ref-type="fig"}D), SOD2 ([Figure 2](#antioxidants-08-00269-f002){ref-type="fig"}F) and catalase (CAT) ([Figure 3](#antioxidants-08-00269-f003){ref-type="fig"}D). This latter protein was monitored through Western blot analysis, as shown in [Figure 3](#antioxidants-08-00269-f003){ref-type="fig"}A. Densitometric analysis was performed and exhibited a significant decrease of CAT protein levels, as shown in [Figure 3](#antioxidants-08-00269-f003){ref-type="fig"}B. The hsa-miR-30a-5p was found to target 3′UTR regions of CAT, as shown in [Figure 3](#antioxidants-08-00269-f003){ref-type="fig"}C. However, other target genes were found to be influenced by KD and linked to antioxidant metabolism and inflammatory-related genes, as shown in [Table 3](#antioxidants-08-00269-t003){ref-type="table"}. Abbreviations and gene names are described in [Table 4](#antioxidants-08-00269-t004){ref-type="table"}.

4. Discussion {#sec4-antioxidants-08-00269}
=============

The World Health Organization states that obesity has nearly tripled since 1975. In 2016, more than 1.9 billion adults were overweight. Of these, over 650 million were obese, leading to the following report sentence: "*Most of the world's population live in countries where overweight and obesity kills more people than underweight. Obesity is preventable*" \[[@B26-antioxidants-08-00269]\]. How can obesity be preventable? One method is represented by KD. The beneficial effects of KD in reducing the body weight and body mass index of obese subjects over both the short (6 weeks) and long (24 weeks) term has already been proven \[[@B12-antioxidants-08-00269],[@B27-antioxidants-08-00269]\]. The administration of KD for a relatively long period is safe and can be considerate a nutritional therapy for weight reduction in obese patients \[[@B27-antioxidants-08-00269]\]. Besides that, to keep KD beneficial, lifestyle change is mandatory and is the harder part of nutritional intervention during KD, with documented improvement of the endurance exercise capacity, better recovery from fatigue and exercise-induced muscle and organ damage prevention in obese subjects. Besides that, the anti-inflammatory action of physical activity was also recently reviewed \[[@B28-antioxidants-08-00269],[@B29-antioxidants-08-00269]\]. Nutraceuticals with antioxidant properties were proposed to help in the treatment of obesity, but they are not enough when taken alone \[[@B30-antioxidants-08-00269]\]. Several scientific approaches to date have tried to describe this disorder by way of genetic or environmental factors \[[@B31-antioxidants-08-00269]\]. The role of epigenetics in human diseases has been well described relatively recently. Obesity and epigenetics is a consolidated union \[[@B32-antioxidants-08-00269],[@B33-antioxidants-08-00269],[@B34-antioxidants-08-00269]\], and bariatric surgery induces epigenetic change in obese subjects \[[@B35-antioxidants-08-00269]\]. We recently reported the influence of the ketogenic diet (KD) on the circulating microRNA (miR) expression profile \[[@B15-antioxidants-08-00269]\]. The 11 miRs controlling the metabolic network identified so far in subjects on KD were almost normalized and closer to lean subjects. Besides that, new miRs targeting identified genes linked to the homeostasis of oxidant--antioxidant pathways were identified. These latter molecules act as epigenetic regulators and have the peculiarity of regulating gene expression targeting the 3′UTR mRNA region \[[@B31-antioxidants-08-00269]\]. Predicted and validated target genes were assessed using DIANA Tools. The hsa-miR-let7e-5p has a role in pathogen recognition \[[@B36-antioxidants-08-00269]\]. A low level of hsa-miR-520h was found in the alteration of the placenta, mediated by oxidative stress \[[@B37-antioxidants-08-00269]\], and hsa-miR-548d-3p was found to be involved in the control of the homeostasis of oxidative stress damage, the metabolic network and survival pathways \[[@B38-antioxidants-08-00269]\]. Here, we found an in silico interaction of that miR with glutathione peroxidase 7 (GPX7), tet methylcytosine dioxygenase 3 (TET3) and superoxide dismutase 2 (SOD2). GPX7 is a glutathione peroxidase homolog for which the exact biochemistry is not fully understood \[[@B39-antioxidants-08-00269]\]. TET3, which is aberrantly expressed in acute myeloid leukemia, promotes DNA oxidation \[[@B40-antioxidants-08-00269],[@B41-antioxidants-08-00269]\]. The mitochondria-localized manganese superoxide, SOD2, has a dichotomous role and aids in the regulation of several types of cancers \[[@B42-antioxidants-08-00269]\]. All those proteins directly or indirectly exhibit a physical interaction with CAT. This latter protein was monitored through Western blot analysis and decreased after KD regime. The hsa-miR-30a-5p was found to target the 3′UTR regions of CAT. It is worth noting that the family of hsa-miR-30, to which hsa-miR-30a-5p belongs, is a promising regulator in both development and disease \[[@B41-antioxidants-08-00269]\]. In the interplay of oxidative stress, pro-oxidants, and antioxidants, this is already known \[[@B43-antioxidants-08-00269]\]. In particular, the regulation of antioxidant genes such as SOD, CAT, and GPX was studied in mice models kept in KD. The short time-frame of KD did not affect the SOD expression protein while it significantly decreased both GPX and CAT \[[@B44-antioxidants-08-00269]\].

5. Conclusions {#sec5-antioxidants-08-00269}
==============

Modulating miRs linked to antioxidant and inflammatory states in obese people might be the key to the success, in particular in the long term, of a nutritional program. The reciprocal action of diet and nutrients on anti-oxidant and anti-inflammatory miRs can present tools to predict and follow the success of a nutritional programs.
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![Heatmap and hierarchical clustering of obese (*n* = 14), lean (*n* = 17) and ketogenic diet (KD) subjects (*n* = 12) based on the most differentially expressed microRNAs. The color and the intensity of the boxes represent changes of gene expression. In the analysis, red represents down-regulated genes and green represents up-regulated genes. Black represents an unchanged expression as evident by the color reference. *n*-Solver software was used.](antioxidants-08-00269-g001){#antioxidants-08-00269-f001}

![Bioinformatics analysis. String protein interaction of (**A**) GPX7 and (**B**) GPX7 in silico interactions with the 3′UTR region. String protein interaction of (**C**) TET3 and its in silico interactions with the 3′UTR region in (**D**). String protein interaction of (**E**) SOD2 and its in silico interactions with the 3′UTR region in (**F**).](antioxidants-08-00269-g002){#antioxidants-08-00269-f002}

![A ketogenic diet (KD) influences catalase gene expression. (**A**) Western blot analysis of catalase (CAT) protein levels in red blood cells from obese, lean and subject in KD. (**B**) Graphical representation of Western blot band intensity, normalized with the loading control GAPDH. (**C**) The CAT gene 3′UTR region interacts with hsa-miR-30a-5p. (**D**) The protein network of CAT enzymes determined by string analysis. Data in panel B represent means ± SD of *n* = 2 for obese, *n* = 3 for lean and *n* = 2 for KD independent tests (\* *p* \< 0.05).](antioxidants-08-00269-g003){#antioxidants-08-00269-f003}

antioxidants-08-00269-t001_Table 1

###### 

Subject characteristics.

  Characteristic   Obese (*n* = 14)   Lean (*n* = 17)   KD (*n* = 12)   *p* Value \*
  ---------------- ------------------ ----------------- --------------- --------------
  Age, y           46.5 ± 10.51       46.83 ±12.32      46.6±11.56      ns
  Height, cm       175.1 ± 5.2        171.3 ± 6.6       176.3 ± 3.3     ns
  Weight, kg       107.5 ± 3.0        70.8 ± 3.8        96.97 ± 11.2    \<0.001
  BMI, kg/m^2^     33.9 ± 1.2         22.1 ± 2.5        31.5 ± 1.3      \<0.001

Data are presented as mean ± SD. \* Using *t* test.

antioxidants-08-00269-t002_Table 2

###### 

Bioinformatics tools for in silico analysis.

  Number of Target Genes                         
  ------------------------ --------------------- -------------
                           miRTargetLink Human   DIANA Tools
  hsa-let-7b-5p            124                   312
  hsa-let-7e-5p            15                    273
  hsa-miR-143-3p           32                    82
  hsa-miR-148b-3p          10                    218
  hsa-miR-26a-5p           52                    391
  hsa-miR-30a-5p           119                   458
  hsa-miR-30e-5p           7                     412
  hsa-miR-502-5p           3                     30
  **hsa-miR-504-5p**       **6**                 **7**
  **hsa-miR-520h**         **5**                 **5**
  hsa-miR-548d-3p          1                     203
  hsa-miR-590-5p           2                     43
  hsa-miR-644a             2                     0
  hsa-miR-877              0                     19

antioxidants-08-00269-t003_Table 3

###### 

Antioxidant metabolism and inflammatory-related genes.

  Biochemical Pathways and Possible miRs Gene Interaction                                                            
  ------------------------------------------------------------------------------------------- ---------------------- ----------------------------------------------------------------------
                                                                                              miRNA                  Validated target genes
  Glutathione metabolism                                                                      hsa-let-7b-5p          GPX7, GSR, RRM2, GGCT
  has-let-7e-5p                                                                               GPX7                   
  hsa-miR-26a-5p                                                                              RRM2                   
  Chondroitin sulfate biosynthesis                                                            hsa-let-7b-5p          CHPF2, XYLT2
  Arachidonic acid metabolism                                                                 hsa-let-7b-5p          CYP2J2, GPX7, LTA4H, PTGS1, PTGS2, PTGES2
  hsa-miR-26a-5p                                                                              PTGS1                  
  hsa-miR-143-3p                                                                              PTGS2                  
  Toll like receptor signalling pathway                                                       hsa-let-7b-5p          IFNB1, NFKBIA, MAPK1, MAP2K2, TAB2
  hsa-miR-26a-5p                                                                              IFNB1, IL6             
  hsa-miR-30e-5p                                                                              CAT                    
  hsa-miR-877-5p                                                                              MAPK8                  
  hsa-miR-148b-3p                                                                             PIK3CA, PIK3CG         
  hsa-miR-143-3p                                                                              AKT1                   
  hsa-miR-520h                                                                                TET3                   
  Natural killer cell mediated cytotoxicity and T Cell, B Cell receptor signalling pathways   hsa-let-7b-5p          IFNB1, NFATC1, NFATC3, NRAS, NFKBIA, PAK1, MAPK1, MAP2K2, PDK1, CD81
  hsa-miR-26a-5p                                                                              IFNB1, SHC2, IL6       
  hsa-miR-30e-5p                                                                              RELA, CAT              
  hsa-miR-504-5p                                                                              FAS                    
  hsa-miR-877-5p                                                                              NFAT5, NRAS, PIK3CCA   
  hsa-miR-143-3p                                                                              HRAS, KRAS, AKT1       
  hsa-miR-148a-3p                                                                             HLA-G, CCL28           
  hsa-miR-548d-3p                                                                             AKT3, SOD2             

antioxidants-08-00269-t004_Table 4

###### 

Abbreviations and gene names.

  Abbreviation   Gene Name
  -------------- -------------------------------------------------------
  AKT1           Serine-threonine protein kinase 1
  AKT3           Serine-threonine protein kinase 3
  CAT            Catalase
  CCL28          C-C motif chemokinine 28 precursor
  CD81           CD81 antigen target proliferate antibody 1
  CHPF2          Chondroitin polymerizing factor 2
  CYP2J2         Cytochrome P450 2J2
  FAS            FAS cell surface deat receptor
  GGCT           Gamma-glutamylcyclotransferase
  GPX7           Glutathione peroxidase 7
  GSR            Glutathione disulphide reductase
  HLA-G          HLA Class I Histocompatibility Antigen, Alpha Chain G
  HRAS           Hras protogoncogene GTPase
  IFNB1          Interferon beta 1
  IL6            Interleukin-6
  KRAS           Kras protogoncogene GTPase
  LTA4H          Leukotriene-A4 hydrolase
  MAP2K2         Mitogen-activated protein kinase 2
  MAPK1          Mitogen-activated protein kinase 1
  MAPK8          Mitogen-activated protein kinase 8
  NFAT5          Nuclear factor of activated T-cells 5
  NFATC1         Nuclear factor of activated T cells 1
  NFATC3         Nuclear factor of activated T cells 3
  NFKBIA         NFKB inhibitor alpha
  NRAS           NRAS-proto-oncogene
  PAK1           Serine/threonine-protein kinase
  PDK1           Phosphoinositide-dependent kinase-1
  PIK3CA         Phosphaidylinositol-3-kinase
  PIK3CG         Phosphaidylinositol-4,5-Bisphosphatase 3-kinase
  PTGES2         Prostaglandin-E synthase 2
  PTGS1          Prostaglandin-endoperoxidase synthase 1
  PTGS2          Prostaglandin-endoperoxdase synthase 2
  PTES2          Prostaglandin-E synthase 2
  RELA           RELA-proto-oncogene
  RRM2           Ribonucleotide reductase regulatory subunit M2
  SHC2           SHC-trasorming protein 2
  TAB2           TGF-beta activated kinase 1 binding protein 2
  XYLT2          Xylosyltransferase 2

[^1]: These authors contributed equally to this work.
